109 related articles for article (PubMed ID: 1379103)
1. Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992.
Harland SJ
Br J Urol; 1992 Jun; 69(6):669. PubMed ID: 1379103
[No Abstract] [Full Text] [Related]
2. Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer.
Fossa SD; Mason M
Br J Urol; 1992 Jan; 69(1):108. PubMed ID: 1371085
[No Abstract] [Full Text] [Related]
3. [Testis cancer markers. Clinical use].
Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
[TBL] [Abstract][Full Text] [Related]
4. Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer.
Lange PH; Hakala TR; Fraley EE
Minn Med; 1975 Nov; 58(11):813-5. PubMed ID: 53783
[No Abstract] [Full Text] [Related]
5. Testicular tumors.
Lightner DJ; Lange PH
Immunol Ser; 1990; 53():397-401. PubMed ID: 1713066
[No Abstract] [Full Text] [Related]
6. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
[No Abstract] [Full Text] [Related]
7. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
8. Diagnostic value of tumour marker regression models in stage 1 marker-positive testicular cancer.
May M; Helke C; Nitzke T; Seehafer M; Vogler H; Hoschke B
Urol Int; 2004; 73(4):329-36. PubMed ID: 15604578
[TBL] [Abstract][Full Text] [Related]
9. Early identification of therapeutic failure in nonseminomatous germ cell tumors by assessing serum tumor marker decline during chemotherapy: still not ready for routine clinical use.
Toner GC
J Clin Oncol; 2004 Oct; 22(19):3842-5. PubMed ID: 15302908
[No Abstract] [Full Text] [Related]
10. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
Fossa SD; Paus E
Prog Clin Biol Res; 1985; 203():121. PubMed ID: 2421325
[No Abstract] [Full Text] [Related]
11. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
12. [Determination of specific markers in the blood in tumors of the testis].
Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
[No Abstract] [Full Text] [Related]
13. The predictive value of pre-orchidectomy serum tumor markers in non seminomatous germ cell tumors of the testis (N.S.G.C.T.T.).
Boccon-Gibod L; Le Doze H; Steg A
Prog Clin Biol Res; 1985; 203():93-5. PubMed ID: 2421347
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous measurement of tumor cytosol and peripheral serum levels of human chorionic gonadotropin and alphafetoprotein in testicular cancer.
Javadpour N; Woltering E; Soares T
Invest Urol; 1980 Jul; 18(1):11-2. PubMed ID: 6157650
[TBL] [Abstract][Full Text] [Related]
15. Serum markers in germ cell neoplasms.
Bartlett NL; Freiha FS; Torti FM
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1245-60. PubMed ID: 1723408
[TBL] [Abstract][Full Text] [Related]
16. Serum alpha fetoprotein and testicular tumors.
N Engl J Med; 1977 Mar; 296(12):693-4. PubMed ID: 65733
[No Abstract] [Full Text] [Related]
17. Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors.
Lange PH; Fraley EE
Urol Clin North Am; 1977 Oct; 4(3):393-406. PubMed ID: 76357
[No Abstract] [Full Text] [Related]
18. Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Schatte EC; Lerner SP
J Urol; 2000 Nov; 164(5):1670. PubMed ID: 11203071
[No Abstract] [Full Text] [Related]
19. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
Weissbach L; Bussar-Maatz R; Mann K
Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
[TBL] [Abstract][Full Text] [Related]
20. [Biological markers in cancer of the testis].
Lotsberg J; Fosså SD; Klepp O; Orjasaeter H; Torjesen PA
Tidsskr Nor Laegeforen; 1980 Apr; 100(12):688-90. PubMed ID: 6158120
[No Abstract] [Full Text] [Related]
[Next] [New Search]
